Gynecological cancers have unique characteristics in women, including estrogen receptor (ER) expression, immune system interactions, and tumor microenvironment dynamics (Kozieł and Piastowska‐Ciesielska 2023). Here, ESR1 is linked to female reproductive organ cancer.